Filter Tube
Jelco Laboratories
FDA Clearance Information
The filter tube was cleared by the FDA through the 510(k) pathway on May 9, 1978. It is manufactured by Jelco Laboratories and classified as a Class 2 device under product code BSN.
What It Is
FDA-Cleared Indications
- Use as a filter tube for filtration of fluids in a clinical setting, as described by the device classification and available record.
- The supplied FDA information does not establish a specific indication for peripheral artery stenting or other named vascular procedures.
Clinical Applications
- Filtration of fluids during procedures in which particulate removal is required.
- Use with compatible catheter-based or vascular equipment when filtration is specified by the applicable device labeling.
- Use in selected vascular procedures only when the complete manufacturer labeling identifies the filter tube as compatible.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- Confirm the exact FDA-cleared configuration, dimensions, connectors, and intended fluid pathway before use; the available record does not list sizes.
- Compatibility with a peripheral stent, guidewire, catheter, injector, or other system should be verified from the original manufacturer labeling.
- Do not assume MRI safety. MRI compatibility, conditional-use conditions, or contraindications require documentation from the manufacturer.
- Inspect the device and packaging before use, follow sterile handling instructions, and discontinue use if the device is damaged, obstructed, or does not function as intended.
- Potential procedural concerns include flow restriction, clot or particulate accumulation, leakage, dislodgment, and infection; risks depend on the complete system and clinical application.
Procedures that use this device
Frequently Asked Questions
What are the clinical indications for filter tube?
The filter tube is indicated for use in peripheral stents, aiding in filtration processes as per FDA documentation.
What outcomes have been reported in clinical studies?
Studies have reported high removal efficiencies for heavy metals and improved flow dynamics in filtration systems.
What complications have been reported?
Safety data indicates the need for frequent back-flushing due to pressure differentials, though it complies with WHO standards.